EXECUTIVE SUMMARY
LAB Pharmaceutical
A niggling pharmaceutical concern has specialities in developing medicates that cigarette cure neurological disorder. It has developed a new drug named, Davanrik, to treat both depression and anxiety. Each drug has to rid of through the three phase clinical approval attend to to have got FDA approval
strain 1 Drug is given to small no of wellnessy volunteer to test the condom of drug
Phase 2-Drug is administered to large no of patient to determine its effectiveness it treating the complaint and to measure its potential side effects
Phase 3- Drug is tried on large no of patient to taste its safety and efficacy
Most of the companys drugs were in phase 2 and Phase 3 testing process scarcely no one was able to pass the FDA approval process. LAB was in financial crisis as its stock prices were falling besides having none FDA approval drug. It decided to search a large pharmaceutical firm so that by licensing it got much needed cash
Davanrik
antidepressant drug drug work by stimulating or cube receptor in the nervous system responsible for mixed moods.
Davanrik not only stimulate the receptor that promotes antidepressant but also it block the receptor that are responsible for hunger. . It was already in the pre-clinical development phase but lacked funds for moreover processes
Merck & co
It is a global company that discovers, develops, manufactures and market various health products both for human and animal. The company is in high product stage during 1998-99. But soon patents of many of its popular drugs exchangeable Vosotec, Mevacor is going to expire which will decrease its tax income and profits. The only way Merck are continue string yield is having enough new drugs in pipe line when the in the first place said drugs patent expire either by internal research or by initiatives with biotechnology
authorize agreement
According to this agreement Merck would be responsible for...If you want to get a full essay, order it on our website: Orderessay
If you want to get a full essay, wisit our page: write my essay .
No comments:
Post a Comment